BioSyntech Canada's IPO

BioSyntech Canada raised a round of funding on March 30, 2004. Investors include Public.

BioSyntech specializes in the discovery, development and manufacturing of biotherapeutic thermogels for regenerative medicine and therapeutic delivery. Its platform technology is a family of hydrogels…

Articles about BioSyntech Canada's IPO: